Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine

• Nuriban Valero-Pacheco ,

  Contributed equally to this work with: Nuriban Valero-Pacheco, Marisol Pérez-Toledo

  Affiliations Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, México, D.F., México

  ⨯
• Marisol Pérez-Toledo ,

  Contributed equally to this work with: Nuriban Valero-Pacheco, Marisol Pérez-Toledo

  Affiliations Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico, Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, México, D.F., México

  ⨯
• Miguel Ángel Villasís-Keever,

  Affiliation Unidad de Investigación en Epidemiología Clínica, Hospital de Pediatría, Centro Médico Nacional “Siglo XXI”, 
Instituto Mexicano del Seguro Social, México, D.F., México

  ⨯
• Adriana Núñez-Valencia,

  Affiliation Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico

  ⨯
• Ilka Boscó-Gárate,

  Affiliation Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico

  ⨯
• Bernardo Lozano-Dubernard,

  Affiliation Departamento de Investigación y Desarrollo, Laboratorio Avi-Mex, S.A. de C.V., México, D.F., México

  ⨯
• Horacio Lara-Puente,

  Affiliation Departamento de Investigación y Desarrollo, Laboratorio Avi-Mex, S.A. de C.V., México, D.F., México

  ⨯
• Clara Espitia,

  Affiliation Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México, D.F., México

  ⨯
• Celia Alpuche-Aranda,

  Affiliation Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México

  ⨯
• Laura C. Bonifaz,

  Affiliation Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico

  ⨯
• Lourdes Arriaga-Pizano,

  Affiliation Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico

  ⨯
• Rodolfo Pastelin-Palacios,

  Affiliation Facultad de Química, Universidad Nacional Autónoma de México, México, D.F., México

  ⨯
• Armando Isibasi,

  Affiliation Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico

  ⨯
• Constantino López-Macías

  * E-mail: constantino@sminmunologia.org

  Affiliations Medical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre “Siglo XXI”, Mexican Social Security Institute, Mexico City, D.F., Mexico, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯